Takeda Pharmaceuticals: Debbie Ransby
Debbie Ransby has been the finance director of Takeda Pharmaceuticals since September 2017 until July 2018.
Debbie Ransby has a CTA from UNISA and is a Chartered Accountant (SA). She began her career at PwC, where numerous dealings with clients such as Pharmacare, Aspen and Ingelheim led her to pursue an interest in healthcare. She assumed a managerial position with GlaxoSmithKline, rising to senior finance manager in her seven years with the pharmaceutical company, before joining Takeda as finance director in September 2017.
Debbie was the winner of the Moving into Africa award at the 2017 CFO Awards.
2018 - Present Managing Director, Takeda Pharmaceuticals
2017 – 2018 Finance Director, Acting Managing Director, Takeda Pharmaceuticals
2008 – 2018 Finance Director Africa, Takeda Pharmaceuticals
2001 – 2008 Senior Finance Manager, GlaxoSmithKline
1992 – 1996 CTA, Auditing, Tax, Economics, Accounting, UNISA
About Takeda Pharmaceuticals: Takeda is patient-focused, innovation-driven global pharmaceutical company with a distinguished 236-year history. The network of Takeda spans over 70 countries and regions worldwide, in Japan, the United States, Europe, Latin America, Africa, the Middle East, and the Asia Pacific Region. Takeda's pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners).